Frontlight ResearchEarly access
CompletedNo phase
Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder
Key facts
- Who runs it
- Asad Ullah Jan
- Where
- Pakistan2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 130 people enrolled
- Started
- 6 May 2025
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- EMDR
- SSRIs
- Record updated
- 7 May 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD) based on DSM-5 criteria
- Willingness to participate and provide informed consent
- Ability to comply with study procedures
Who cannot take part
- Current diagnosis of psychotic disorder, bipolar disorder, or severe major depressive episode with psychotic features
- Active substance use disorder within the past 6 months
- Severe cognitive impairment or inability to complete study assessments
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial investigates the comparative effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy and selective serotonin reuptake inhibitors (SSRIs) in fostering post-traumatic growth among patients diagnosed with post-traumatic stress disorder (PTSD). Participants will be randomized to receive either EMDR therapy or standard SSRI pharmacotherapy. The primary objective is to evaluate the extent of psychological growth and recovery achieved through each intervention, aiming to guide future therapeutic strategies for PTSD.
The 2 groups in the trial
- EMDRTreatment being tested
EMDR therapy
- SSRIsExisting treatment, for comparison
Acting as control group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder: A Randomized Controlled Trial
- Record updated
- 7 May 2026